| Literature DB >> 19464089 |
Michael Staun1, Loris Pironi, Federico Bozzetti, Janet Baxter, Alastair Forbes, Francesca Joly, Palle Jeppesen, Jose Moreno, Xavier Hébuterne, Marek Pertkiewicz, Stefan Mühlebach, Alan Shenkin, André Van Gossum.
Abstract
Home parenteral nutrition (HPN) was introduced as a treatment modality in the early 1970s primarily for the treatment of chronic intestinal failure in patients with benign disease. The relatively low morbidity and mortality associated with HPN has encouraged its widespread use in western countries. Thus there is huge clinical experience, but there are still few controlled clinical studies of treatment effects and management of complications. The purpose of these guidelines is to highlight areas of good practice and promote the use of standardized treatment protocols between centers. The guidelines may serve as a framework for development of policies and procedures.Entities:
Mesh:
Year: 2009 PMID: 19464089 DOI: 10.1016/j.clnu.2009.04.001
Source DB: PubMed Journal: Clin Nutr ISSN: 0261-5614 Impact factor: 7.324